UA41361C2 - Моноефірні сполуки та фармацевтична композиція для лікування вірусних інфекцій - Google Patents

Моноефірні сполуки та фармацевтична композиція для лікування вірусних інфекцій

Info

Publication number
UA41361C2
UA41361C2 UA95104367A UA95104367A UA41361C2 UA 41361 C2 UA41361 C2 UA 41361C2 UA 95104367 A UA95104367 A UA 95104367A UA 95104367 A UA95104367 A UA 95104367A UA 41361 C2 UA41361 C2 UA 41361C2
Authority
UA
Ukraine
Prior art keywords
treatment
rybofuranose
pharmaceutical composition
viral infections
monoether compounds
Prior art date
Application number
UA95104367A
Other languages
English (en)
Russian (ru)
Inventor
Бернт Бьорретсен
Бернт БЕРРЕТСЕН
Аре ДАЛЕН
Фінн МЮХРЕН
Финн Мюхрен
Хелль Тургеір Стокке
Хелль Тургеир Стокке
Original Assignee
Норск Хюдро А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Норск Хюдро А.С. filed Critical Норск Хюдро А.С.
Publication of UA41361C2 publication Critical patent/UA41361C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Моноефірна сполука формули : Nu – О – Fa, де О є киснем, Nu є аналогом нуклеозиду, Fa є ацильною групою мононенасиченої С18 або С20 ω-9 жирної кислоти, причому ця жирна кислота етерифікує гідроксильну групу в 5'- положенні цукрової частини нуклеозидного аналога або кінцеву гідроксильну групу на нециклічній групі нуклеозидного аналога, і причому Nu представлено формулою II: У – S, де S є моносахаридним похідним, що вибирається з: ω- D -рибофуранози, 1- β -D -арабінофуранози, 2-дезокси-1- β -D -рибофуранози, 2, З – дідезокси -1- β -D -рибофуранози, 4-гідрокси-метил-2-циклопентен-1-ілу або 2, 3-дігідроксипропілу; і В є гетероциклічною кільцевою системою, що вибирається з наступних формул: де R1 = NH2, Y = С=СН; або де R2 = Н, OH, РЗ = Н, OH, NH2; або де R4 = NH2, R5 = Н; R6 = СН3, F, I; за умови, що коли S є 1- β -D – арабінофуранозою, В не може бути:
UA95104367A 1993-04-05 1994-04-05 Моноефірні сполуки та фармацевтична композиція для лікування вірусних інфекцій UA41361C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307043A GB9307043D0 (en) 1993-04-05 1993-04-05 Chemical compounds
PCT/NO1994/000071 WO1994022887A1 (en) 1993-04-05 1994-04-05 New antiviral compounds

Publications (1)

Publication Number Publication Date
UA41361C2 true UA41361C2 (uk) 2001-09-17

Family

ID=10733340

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95104367A UA41361C2 (uk) 1993-04-05 1994-04-05 Моноефірні сполуки та фармацевтична композиція для лікування вірусних інфекцій

Country Status (20)

Country Link
US (1) US6153594A (uk)
EP (1) EP0693077B1 (uk)
JP (1) JP3049258B2 (uk)
KR (1) KR100309194B1 (uk)
AT (1) ATE171457T1 (uk)
AU (1) AU685104B2 (uk)
CA (1) CA2158853C (uk)
CZ (1) CZ287755B6 (uk)
DE (1) DE69413529T2 (uk)
DK (1) DK0693077T3 (uk)
ES (1) ES2124883T3 (uk)
FI (1) FI111370B (uk)
GB (1) GB9307043D0 (uk)
HU (1) HU228064B1 (uk)
NZ (1) NZ263888A (uk)
PL (1) PL177263B1 (uk)
RU (1) RU2139884C1 (uk)
SK (1) SK281231B6 (uk)
UA (1) UA41361C2 (uk)
WO (1) WO1994022887A1 (uk)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515279D0 (en) * 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
DE69812934T2 (de) * 1997-01-24 2004-01-29 Conpharma As Oslo Gemcitabin-derivate
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
AU1412299A (en) * 1997-11-25 1999-06-15 Protarga, Inc. Nucleoside analog compositions and uses thereof
EP1095947B1 (en) 1998-07-09 2007-03-14 Sankyo Company Limited Novel antibacterial compounds
AU5475799A (en) * 1998-08-10 2000-03-06 Centre National De La Recherche Scientifique Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis
US6277830B1 (en) 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
AU762395B2 (en) * 1998-10-16 2003-06-26 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
US6403564B1 (en) 1998-10-16 2002-06-11 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
AU2001255495A1 (en) * 2000-04-20 2001-11-07 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rnain patients having chronic hepatitis c infection
PY0111577A (es) 2000-05-23 2017-01-02 Idenix Cayman Ltd Métodos y composiciones para el tratamiento del virus de la hepatitis c
BR0111196A (pt) 2000-05-26 2004-04-06 Idenix Cayman Ltd Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
WO2003062388A2 (en) * 2002-01-16 2003-07-31 The Regents Of The University Of California Inhibition of rna function
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
AP2005003213A0 (en) 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
CA2503890A1 (en) * 2002-11-01 2004-05-13 Evogenix Pty Ltd Mutagenesis methods using ribavirin and/or rna replicases
RU2005118421A (ru) 2002-11-15 2006-01-20 Айденикс (Кайман) Лимитед (Ky) 2'-разветвленные нуклеозиды и мутация flaviviridae
TWI332507B (en) 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
AU2003300901A1 (en) 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
EP1745573A4 (en) * 2003-03-20 2010-05-26 Microbiol Quimica Farmaceutica PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
KR20060092242A (ko) * 2003-11-03 2006-08-22 코그니스 아이피 매니지먼트 게엠베하 아실 리보뉴클레오시드 및 아실 데옥시리보뉴클레오시드
FR2874016B1 (fr) 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
US9029345B2 (en) * 2005-03-16 2015-05-12 Case Western Reserve University Selective inhibitors of translesion DNA replication
WO2006101911A1 (en) 2005-03-16 2006-09-28 Case Western Reserve University Selective inhibitors of translesion dna replication
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2009042766A1 (en) * 2007-09-26 2009-04-02 Mount Sinai School Of Medicine Azacytidine analogues and uses thereof
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3A (en) * 1836-08-01 1836-08-11 Thomas Blanchard Machine for turning and wooden sheaves and pins for ships' tackle blocks and pulleys
GB1325798A (en) * 1970-09-24 1973-08-08 Upjohn Co Derivatives of 2,2-anhydro-ara-cytidine
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US3998807A (en) * 1972-03-03 1976-12-21 Syntex (U.S.A.) Inc. Arabinofuranosyl cytosines and methods of making
GB1482736A (en) * 1974-03-18 1977-08-10 Icn Pharmaceuticals 1-(beta-d-ribofuranosyl)-1,2,4-triazole acid derivatives
US3960836A (en) * 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
JPS5159880A (en) * 1974-11-22 1976-05-25 Asahi Chemical Ind N44 ashirunukureoshidojikarubonsanesuteruno seiho
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
JPH0655755B2 (ja) * 1985-01-23 1994-07-27 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシウリジン−３′−ホスフエ−ト誘導体およびその塩
US4684631A (en) * 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
JPS6483092A (en) * 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
EP0355031A3 (de) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
JPH0278696A (ja) * 1988-09-13 1990-03-19 Shoichiro Ozaki ５−フルオロウラシル誘導体
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
EP0450102A4 (en) * 1989-10-26 1992-05-06 Yamasa Shoyu Kabushiki Kaisha Nucleoside derivative
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
RU2071773C1 (ru) * 1993-07-19 1997-01-20 Товарищество с ограниченной ответственностью "Полисан" Лекарственное средство для лечения синдромов приобретенного иммунодефицита, в том числе вич-обусловленных

Also Published As

Publication number Publication date
HUT73659A (en) 1996-09-30
SK281231B6 (sk) 2001-01-18
AU685104B2 (en) 1998-01-15
JP3049258B2 (ja) 2000-06-05
DE69413529D1 (de) 1998-10-29
CA2158853A1 (en) 1994-10-13
HU228064B1 (en) 2012-09-28
ES2124883T3 (es) 1999-02-16
CZ259395A3 (en) 1996-06-12
PL310970A1 (en) 1996-01-22
NZ263888A (en) 1998-05-27
DE69413529T2 (de) 1999-04-29
AU6514194A (en) 1994-10-24
DK0693077T3 (da) 1999-06-14
PL177263B1 (pl) 1999-10-29
HK1003437A1 (en) 1998-10-30
HU9502896D0 (en) 1995-11-28
CA2158853C (en) 1999-07-27
FI111370B (fi) 2003-07-15
RU2139884C1 (ru) 1999-10-20
WO1994022887A1 (en) 1994-10-13
EP0693077A1 (en) 1996-01-24
FI954727L (fi) 1995-10-04
EP0693077B1 (en) 1998-09-23
CZ287755B6 (en) 2001-01-17
KR100309194B1 (ko) 2002-06-20
FI954727A0 (fi) 1995-10-04
ATE171457T1 (de) 1998-10-15
GB9307043D0 (en) 1993-05-26
US6153594A (en) 2000-11-28
SK123395A3 (en) 1996-04-03
JPH08508477A (ja) 1996-09-10

Similar Documents

Publication Publication Date Title
UA41361C2 (uk) Моноефірні сполуки та фармацевтична композиція для лікування вірусних інфекцій
DE3763011D1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
DK387889D0 (da) Makrolider, og farmaceutiske praeparater med indhold af saadanne forbindelser
RU95119386A (ru) Новые противовирусные вещества
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
UA39131C2 (uk) Склад для обробки порожнини рота
RU94021110A (ru) Сложные эфиры нуклеозида и его производных, фармацевтическая композиция на их основе и способ лечения
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
EP0642525A1 (en) Chemical compounds.
ZA9410196B (en) Branched-amino-substituted thiazoles processes for their preparation and the pharmaceutical compositions which contain them
ES8701761A1 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
JPS5791998A (en) Novel 5'-o-acylnucleoside derivative and its preparation
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
SG39892G (en) 4,5-dihydro-oxazole derivatives,process for their preparation and their use
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
IL75357A (en) Primycin components,process for the separation of the antibiotic complex and antibiotic pharmaceutical compositions containing them
JPS5424895A (en) Pyranochromone derivatives and remedies for allergic disorder
IE790003L (en) Oleandomycin derivatives
JPS5248626A (en) Disaccharide derivatives and their preparation process
PT79537A (en) Process for preparing polyether antibiotics and of antibiotic compositions containing the same
JPS6461494A (en) Production of 5'-0-acyl-5-fluorouridine derivative
GB2230953B (en) Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease
JPS55124717A (en) Anticomplement activating agent